DrugPatentWatch Database Preview
XURIDEN Drug Profile
When do Xuriden patents expire, and when can generic versions of Xuriden launch?
Xuriden is a drug marketed by Wellstat Therap and is included in one NDA. There is one patent protecting this drug.
This drug has one hundred and seventy-five patent family members in twenty-one countries.
The generic ingredient in XURIDEN is uridine triacetate. There are thirty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the uridine triacetate profile page.
Summary for XURIDEN
| International Patents: | 175 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 55 |
| Patent Applications: | 51 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | XURIDEN at DailyMed |
Pharmacology for XURIDEN
| Ingredient-type | Pyrimidines Analogs/Derivatives |
| Drug Class | Pyrimidine Analog |
Synonyms for XURIDEN
| (2R,3R,4R,5R)-2-(ACETOXYMETHYL)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-3,4-DIYL DIACETATE |
| [(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate |
| [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate |
| 105T388 |
| 2 ,3 ,5 -Triacetyluridine |
| 2',3',5'-Tri-O-acetyluridine |
| 2',3',5'-Tri-O-acetyluridine, >=98% |
| 293738-13-3 |
| 2WP61F175M |
| 4105-38-8 |
| AC1L2FGB |
| AK-73070 |
| AKOS015964563 |
| AN-158 |
| ANW-29551 |
| API0001026 |
| AUFUWRKPQLGTGF-FMKGYKFTSA-N |
| AX8007900 |
| CHEBI:90914 |
| CHEMBL2107381 |
| CTK3J5861 |
| D09985 |
| DB09144 |
| EINECS 223-881-5 |
| FT-0081134 |
| J-700012 |
| KSC495Q6D |
| MFCD00023795 |
| MLS006009982 |
| MolPort-005-940-324 |
| PN 401 |
| PN401 |
| PubChem14176 |
| RG 2133 |
| SB18970 |
| SCHEMBL871011 |
| SMR004701034 |
| Tri-O-acetyluridine |
| triacetyl uridine |
| Triacetyluridine |
| UNII-2WP61F175M |
| URI007 |
| Uridine 2',3',5'-triacetate |
| Uridine triacetate |
| Uridine triacetate (USAN/INN) |
| Uridine triacetate [USAN:INN] |
| Uridine, 2',3',5'-triacetate |
| Vistogard |
| Vistonuridine |
| Xuriden (TN) |
| ZINC3843198 |
US Patents and Regulatory Information for XURIDEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellstat Therap | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Wellstat Therap | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Wellstat Therap | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for XURIDEN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Hong Kong | 1005703 | Start Trial |
| Japan | H02500373 | Start Trial |
| Portugal | 1491201 | Start Trial |
| Japan | 2007332144 | Start Trial |
| Hong Kong | 1072897 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for XURIDEN
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1849470 | CA 2017 00036 | Denmark | Start Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF TIPIRACIL; REG. NO/DATE: EU/1/16/1096 20160427 |
| 1849470 | 1790063-0 | Sweden | Start Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1096 20160427 |
| 1849470 | 2017/033 | Ireland | Start Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160425 |
| 1849470 | 2017C/028 | Belgium | Start Trial | PRODUCT NAME: LONSURF - TRIFLURIDINE/TIPIRACIL; AUTHORISATION NUMBER AND DATE: EU/1/16/1096 20160427 |
| 1849470 | LUC00036 | Luxembourg | Start Trial | PRODUCT NAME: TRIFLURIDINE COMBINEE AU TIPIRACIL OU UN SEL DE TIPIRACIL TEL QUE L'HYDROCHLORURE DE TIPIRACIL; AUTHORISATION NUMBER AND DATE: EU/1/16/1096 20160427 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
